Search Results 101-110 of 8352 for TNF

1. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

   Demonstrated intolerance or inadequate response to one or more anti-tumor necrosis factor (TNF) therapies. Exclusion Criteria: Current diagnosis of ...

2. Endoscopic Procedures Clinical Trials - Mayo Clinic Research

   ... Tumor Necrosis Factor (TNF) therapy. A Study to Evaluate the Otonexus Ultrasound Otoscope Rochester, MN. The purpose of this study is to evaluate usability ...

3. Publications - Lester E. Mertz, M.D. - Mayo Clinic

   ... Tumor Necrosis Factor alpha. Clin Infect Dis. 2019 Mar 5; 68 (6):1024-1030. View PubMed; Nokes B, Tseng AS, Cartin-Ceba R, Shamoun F, Jokerst C, Mertz L ...

4. A Study of the Safety and Effectiveness of Combined Copaxone and Estriol for Relapsing Remitting Multiple Sclerosis - Mayo Clinic

   ... TNF-alpha, and IFN-gamma). Significantly increased levels of IL-5 and IL-10 ... TNF-alpha were observed in stimulated PBMC isolated during estriol treatment.

5. Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL - Mayo Clinic

   Being treated with anti-TNF therapies or has been treated with an anti-TNF therapy within 5 half-lives of randomization. Participating Mayo Clinic locations.

6. A Study to Evaluate the Safety and Effectiveness of BMS-986165 in Subjects with Moderate-to-Severe Ulcerative Colitis (UC) - Mayo Clinic

   ... tumor necrosis factor (TNF)-α agents, integrin inhibitor. Exclusion Criteria: Participant with current diagnosis of Crohn's disease (CD) or diagnosis of ...

7. Nhan L. Tran, Ph.D. - Mayo Clinic Faculty Profiles

   Tumor necrosis factor receptor superfamily biology in cancer; Identification of novel drug targets, high-throughput screening for drug discovery and ...

8. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

   Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns ...

9. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

   Patient must receive anti-TNF treatment within 2 months following enrollment into the registry. Patient is currently receiving immunosuppressant therapy for ...

10. A Study to Evaluate Safety and Effectiveness of SHP647 as Induction Therapy in Participants with Moderate-to- Severe Crohn's Disease - Mayo Clinic

    ... TNF. Subjects who have had an inadequate response to sulfasalazine or mesalamine should have also failed at least 1 other conventional treatment such as ...